Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2014, Article ID 108185, 4 pages
http://dx.doi.org/10.1155/2014/108185
Case Report

Ceftriaxone-Induced Acute Encephalopathy in a Peritoneal Dialysis Patient

Division of Nephrology and Hypertension, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA

Received 16 September 2014; Revised 9 November 2014; Accepted 17 November 2014; Published 7 December 2014

Academic Editor: Bernard Jaar

Copyright © 2014 Sami Safadi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. McNally, A. Pithie, and D. Jardine, “Cefepime: a rare cause of encephalopathy,” Internal Medicine Journal, vol. 42, no. 6, pp. 732–733, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C.-J. Lin, S.-P. Chen, S.-J. Wang, and J.-L. Fuh, “Cefepime-related encephalopathy in peritoneal dialysis patients,” Journal of the Chinese Medical Association, vol. 74, no. 2, pp. 87–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Roncon-Albuquerque Jr., I. Pires, R. Martins, R. Real, G. Sousa, and P. von Hafe, “Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection,” Netherlands Journal of Medicine, vol. 67, no. 2, pp. 72–75, 2009. View at Google Scholar · View at Scopus
  4. J. Lazarou, B. H. Pomeranz, and P. N. Corey, “Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies,” The Journal of the American Medical Association, vol. 279, no. 15, pp. 1200–1205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Francis, D. Martin, and W. N. Kapoor, “A prospective study of delirium in hospitalized elderly,” Journal of the American Medical Association, vol. 263, no. 8, pp. 1097–1101, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Prajapati and B. Ganguly, “Appropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: a cross-sectional study,” Journal of Pharmacy and Bioallied Sciences, vol. 5, no. 2, pp. 136–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. K. Verbeeck and F. T. Musuamba, “Pharmacokinetics and dosage adjustment in patients with renal dysfunction,” European Journal of Clinical Pharmacology, vol. 65, no. 8, pp. 757–773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Papaioannou, J.-A. Clarke, G. Campbell, and M. Bedard, “Assessment of adherence to renal dosing guidelines in long-term care facilities,” Journal of the American Geriatrics Society, vol. 48, no. 11, pp. 1470–1473, 2000. View at Google Scholar · View at Scopus
  9. C. L. Long, M. A. Raebel, D. W. Price, and D. J. Magid, “Compliance with dosing guidelines in patients with chronic kidney disease,” Annals of Pharmacotherapy, vol. 38, no. 5, pp. 853–858, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Farag, A. X. Garg, L. Li, and A. K. Jain, “Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis,” American Journal of Kidney Diseases, vol. 63, no. 3, pp. 422–428, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. K.-T. Li, C. C. Szeto, B. Piraino et al., “Peritoneal dialysis-related infections recommendations: 2010 update,” Peritoneal Dialysis International, vol. 30, no. 4, pp. 393–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Calandra, E. Lydick, J. Carrigan, L. Weiss, and H. Guess, “Factors predisposing to seizures in seriously III infected patients receiving antibiotics: experience with imipenem/cilastatin,” American Journal of Medicine, vol. 84, no. 5, pp. 911–918, 1988. View at Publisher · View at Google Scholar · View at Scopus
  13. J. R. Koup, E. Keller, H. Neumann, and K. Stoeckel, “Ceftriaxone pharmacokinetics during peritoneal dialysis,” European Journal of Clinical Pharmacology, vol. 30, no. 3, pp. 303–307, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. I. H. Patel and S. A. Kaplan, “Pharmacokinetic profile of ceftriaxone in man,” The American Journal of Medicine, vol. 77, no. 4C, pp. 17–25, 1984. View at Google Scholar · View at Scopus
  15. R. Pharmaceuticals, Ceftriaxone Sodium Powder for Injection, vol. 4, Product Information, 2013.
  16. T. Y. Ti, L. Fortin, J. H. Kreeft, D. S. East, R. I. Ogilvie, and P. J. Somerville, “Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis,” Antimicrobial Agents and Chemotherapy, vol. 25, no. 1, pp. 83–87, 1984. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Albin, J. M. Ragnaud, F. Demotes-Mainard, G. Vinçon, M. Couzineau, and C. Wone, “Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis,” European Journal of Clinical Pharmacology, vol. 31, no. 4, pp. 479–483, 1986. View at Publisher · View at Google Scholar · View at Scopus
  18. A. de Sarro, D. Ammendola, M. Zappala, S. Grasso, and G. B. de Sarro, “Relationship between structure and convulsant properties of some β-lactam antibiotics following intracerebroventricular microinjection in rats,” Antimicrobial Agents and Chemotherapy, vol. 39, no. 1, pp. 232–237, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. G. K. Dakdouki and G. N. Al-War, “Cefepime-induced encephalopathy,” International Journal of Infectious Diseases, vol. 8, no. 1, pp. 59–61, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. F. S. Sharif-Askari, S. A. S. Sulaiman, N. S. Sharif-Askari, and A. A. S. Hussain, “Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease,” PLoS ONE, vol. 9, no. 4, Article ID e95991, 2014. View at Publisher · View at Google Scholar · View at Scopus